Correction: Vol. 30, No. 6

Correction: Vol. 30, No. 6 Volume 31, Number 7—July 2025 Altmetrics Click a source for Altmetric details What is the Altmetric Attention Score? The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received....

FDA approves taletrectinib

On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).Full prescribing information for Ibtrozi will be...

Correction: Vol. 30, No. 8

Correction: Vol. 30, No. 8 Volume 31, Number 7—July 2025 Altmetrics Click a source for Altmetric details What is the Altmetric Attention Score? The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received....

Submit Demonstration Program Proposal

Content and Format of the C3TI Demonstration Program ProposalThe C3TI Demonstration Program proposal should include the information below and not exceed 10 pages. The sponsor should indicate in their proposal if any items listed below do not pertain to their proposal....